FDA Inspection 1199219 — Confab Laboratories Inc.
The FDA completed an inspection of Confab Laboratories Inc. on Feb 3, 2023 in Saint-Hubert. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 3, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint-Hubert (Canada)